Cargando…

Evolution of Angiotensin Peptides and Peptidomimetics as Angiotensin II Receptor Type 2 (AT2) Receptor Agonists

Angiotensin II receptor type 1 and 2 (AT1R and AT2R) are two G-protein coupled receptors that mediate most biological functions of the octapeptide Angiotensin II (Ang II). AT2R is upregulated upon tissue damage and its activation by selective AT2R agonists has become a promising approach in the sear...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vasile, Silvana, Hallberg, Anders, Sallander, Jessica, Hallberg, Mathias, Åqvist, Johan, Gutiérrez-de-Terán, Hugo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7226584/ https://www.ncbi.nlm.nih.gov/pubmed/32340100 http://dx.doi.org/10.3390/biom10040649

Ejemplares similares

Direct Angiotensin AT2 Receptor Stimulation Using a Novel AT2 Receptor Agonist, Compound 21, Evokes Neuroprotection in Conscious Hypertensive Rats
por: McCarthy, Claudia A., et al.
Publicado: (2014)

Angiotensin II, a Neuropeptide at the Frontier between Endocrinology and Neuroscience: Is There a Link between the Angiotensin II Type 2 Receptor and Alzheimer’s Disease?
por: Gallo-Payet, Nicole, et al.
Publicado: (2011)

A Series of Analogues to the AT(2)R Prototype Antagonist C38 Allow Fine Tuning of the Previously Reported Antagonist Binding Mode
por: Isaksson, Rebecka, et al.
Publicado: (2019)

Structural and Energetic Effects of A(2A) Adenosine Receptor Mutations on Agonist and Antagonist Binding
por: Keränen, Henrik, et al.
Publicado: (2014)

Structural Basis of Inhibition of Human Insulin-Regulated Aminopeptidase (IRAP) by Benzopyran-Based Inhibitors
por: Vanga, Sudarsana Reddy, et al.
Publicado: (2021)

N-Aryl Isoleucine Derivatives as Angiotensin II AT(2) Receptor Ligands
por: Behrends, Malte, et al.
Publicado: (2014)

Structural Basis of Inhibition of Human Insulin-Regulated Aminopeptidase (IRAP) by Aryl Sulfonamides
por: Vanga, Sudarsana Reddy, et al.
Publicado: (2018)

From Angiotensin IV to Small Peptidemimetics Inhibiting Insulin-Regulated Aminopeptidase
por: Hallberg, Mathias, et al.
Publicado: (2020)

Seven days treatment with the angiotensin II type 2 receptor agonist C21 in hospitalized COVID-19 patients; a placebo-controlled randomised multi-centre double-blind phase 2 trial
por: Tornling, Göran, et al.
Publicado: (2021)

The angiotensin II receptor type 2 agonist CGP 42112A stimulates NO production in the porcine jejunal mucosa
por: Ewert, Sara, et al.
Publicado: (2003)

Effect of angiotensin receptor blockers and angiotensin converting enzyme 2 on plasma equilibrium angiotensin peptide concentrations in dogs with heart disease
por: Larouche‐Lebel, Éva, et al.
Publicado: (2020)

Effect of angiotensin receptor blockers and angiotensin‐converting enzyme 2 on plasma equilibrium angiotensin peptide concentrations in cats with heart disease
por: Huh, Terry, et al.
Publicado: (2020)

Computational Prediction of Alanine Scanning and Ligand Binding Energetics in G-Protein Coupled Receptors
por: Boukharta, Lars, et al.
Publicado: (2014)

Receptors | Angiotensin Receptors
por: Pardhi, Triveni R., et al.
Publicado: (2021)

Rapid de novo discovery of peptidomimetic affinity reagents for human angiotensin converting enzyme 2
por: Zhang, Genwei, et al.
Publicado: (2022)

Angiotensin Type 2 Receptors: Painful, or Not?
por: Pulakat, Lakshmi, et al.
Publicado: (2020)

Genome-wide association study of angioedema induced by angiotensin-converting enzyme inhibitor and angiotensin receptor blocker treatment
por: Rasmussen, Eva Rye, et al.
Publicado: (2020)

Decoding Angiotensin Receptors: TOMAHAQ‐Based Detection and Quantification of Angiotensin Type‐1 and Type‐2 Receptors
por: Cosarderelioglu, Caglar, et al.
Publicado: (2023)

β-Arrestin–Biased Angiotensin II Receptor Agonists for COVID-19
por: Manglik, Aashish, et al.
Publicado: (2020)

Chemopreventive effects of angiotensin II receptor type 2 agonist on prostate carcinogenesis by the down-regulation of the androgen receptor
por: Ito, Yusuke, et al.
Publicado: (2018)

Synergism between Angiotensin receptors ligands: Role of Angiotensin‐(1‐7) in modulating AT(2)R agonist response on nitric oxide in kidney cells
por: Patel, Sanket, et al.
Publicado: (2020)

GPCR-ModSim: A comprehensive web based solution for modeling G-protein coupled receptors
por: Esguerra, Mauricio, et al.
Publicado: (2016)

Facilitation of TRKB Activation by the Angiotensin II Receptor Type-2 (AT2R) Agonist C21
por: Laukkanen, Liina, et al.
Publicado: (2021)

Neuroprotective effect of an angiotensin receptor type 2 agonist following cerebral ischemia in vitro and in vivo
por: Lee, Seyoung, et al.
Publicado: (2012)

Effects of SGLT2 Inhibitors and GLP-1 Receptor Agonists on Renin-Angiotensin-Aldosterone System
por: Puglisi, Soraya, et al.
Publicado: (2021)

Receptor Interactions of Angiotensin II and Angiotensin Receptor Blockers—Relevance to COVID-19
por: Moore, Graham J., et al.
Publicado: (2021)

Structural determinants for binding to angiotensin converting enzyme 2 (ACE2) and angiotensin receptors 1 and 2
por: Clayton, Daniel, et al.
Publicado: (2015)

Angiotensin-Converting Enzyme 2 and Antihypertensives (Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors) in Coronavirus Disease 2019
por: Sanchis-Gomar, Fabian, et al.
Publicado: (2020)

Angiotensin Converting Enzyme 2, Angiotensin-(1-7), and Receptor Mas Axis in the Kidney
por: Pinheiro, Sergio Veloso Brant, et al.
Publicado: (2012)

Local Angiotensin Generation and AT(2) Receptor Activation
por: Esch, Joep H.M. Van, et al.
Publicado: (2007)

Does a selective non-peptide angiotensin II type 2 receptor agonist reduce post-infarction left ventricular remodeling?
por: Jehle, Alexander B, et al.
Publicado: (2009)

Devil and angel in the renin–angiotensin system: ACE–angiotensin II–AT(1) receptor axis vs. ACE2–angiotensin-(1–7)–Mas receptor axis
por: Iwai, Masaru, et al.
Publicado: (2009)

Synthesis, Evaluation and Proposed Binding Pose of Substituted Spiro‐Oxindole Dihydroquinazolinones as IRAP Inhibitors
por: Engen, Karin, et al.
Publicado: (2020)

Angiotensin-Converting Enzyme 2 and the Resolution of Inflammation: In Support of Continuation of Prescribed Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers
por: Gersh, Felice L.
Publicado: (2020)

Effects of the Oral Angiotensin II Type 2 Receptor Agonist C21 in Sugen-Hypoxia Induced Pulmonary Hypertension in Rats
por: Tornling, Göran, et al.
Publicado: (2023)

From Angiotensin II to Cyclic Peptides and Angiotensin Receptor Blockers (ARBs): Perspectives of ARBs in COVID-19 Therapy
por: Matsoukas, John, et al.
Publicado: (2021)

Angiotensin-(1-7)/Angiotensin-Converting Enzyme 2/Mas Receptor Axis and Related Mechanisms
por: Ferreira, Anderson J., et al.
Publicado: (2012)

Effects of a PPAR -gamma receptor agonist and an angiotensin receptor antagonist on aortic contractile responses to alpha receptor agonists in diabetic and/or hypertensive rats
por: Tugrul, Ibrahim, et al.
Publicado: (2016)

Angiotensin receptors and neuropathic pain
por: Balogh, Mihály, et al.
Publicado: (2021)

Adenoviral Delivery of Angiotensin-(1-7) or Angiotensin-(1-9) Inhibits Cardiomyocyte Hypertrophy via the Mas or Angiotensin Type 2 Receptor
por: Flores-Muñoz, Monica, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_o05s9814mq7uebj81kmbmt5u1l